MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
1431.16%
Quick Ratio
1431.16%
Cash Ratio
1284.65%
Debt to Asset Ratio
15.47%
Unit: Dollar
Assets Breakdown
Cash and cash equivalents
Goodwill
Intangible assets, net
Prepaid expenses
Liabilities Breakdown
Aadditional paid-in capital, net...
Accumulated deficit
Accompanying warrants liability
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Restricted cash
-
-
-
0
Cash and cash equivalents
19,440,655
22,170,414
13,649,638
14,210,745
Accounts receivable, non-trade
1,605,340
1,109,908
1,758
11,948
Restricted cash
-
79,647
78,564
77,945
Prepaid expenses
611,913
26,954
222,319
740,193
Total current assets
21,657,908
23,386,923
13,952,279
15,040,831
Property and equipment, net
-
-
2,573
2,771
Intangible assets, net
4,307,743
4,473,426
4,639,108
4,804,791
Operating lease right-of-use assets
-
-
75,219
102,612
Goodwill
8,843,549
8,737,953
8,674,734
8,638,609
Total assets
34,809,200
36,598,302
27,343,913
28,589,614
Operating lease liability, net of current portion
-
-
-
0
Other non-current liabilities
-
-
-
0
Accounts payable
627,185
520,709
1,370,728
1,154,369
Accrued expenses and other current liabilities
886,124
2,065,599
3,668,338
2,950,077
Operating lease liability
-
-
85,210
116,314
Total current liabilities
1,513,309
2,586,308
5,124,276
4,220,760
Contingent consideration
1,023,839
1,172,859
1,156,912
1,169,675
Deferred tax liability
390,733
425,527
460,320
495,113
Accompanying warrants liability
2,457,375
2,712,784
8,092,218
3,701,492
Total liabilities
5,385,256
6,897,478
14,833,726
9,587,040
Common stock, 0.00001 par value, 5,377,329 and 1,978,460 shares issued and outstanding at march 31, 2026 and june 30, 2025, respectively
54
54
23
19
Aadditional paid-in capital, net of subscription receivable
218,385,436
218,315,150
203,559,216
200,194,324
Accumulated other comprehensive loss, net of tax
-2,067,368
-2,225,265
-2,795,845
-2,845,066
Accumulated deficit
-186,894,178
-186,389,115
-188,253,207
-178,346,703
Total shareholders equity
29,423,944
29,700,824
12,510,187
19,002,574
Total liabilities and shareholders equity
34,809,200
36,598,302
27,343,913
28,589,614
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$19,440,655
Accounts receivable,
non-trade
$1,605,340
Prepaid expenses
$611,913
Total current assets
$21,657,908
Goodwill
$8,843,549
Intangible assets, net
$4,307,743
Total assets
$34,809,200
Total liabilities and
shareholders equity
$34,809,200
Total shareholders
equity
$29,423,944
Total liabilities
$5,385,256
Accumulated deficit
-$186,894,178
Accumulated other
comprehensive loss, net of tax
-$2,067,368
Aadditional paid-in
capital, net of...
$218,385,436
Accompanying warrants
liability
$2,457,375
Total current
liabilities
$1,513,309
Contingent consideration
$1,023,839
Deferred tax liability
$390,733
Common stock, 0.00001
par value,...
$54
Accrued expenses and
other current...
$886,124
Accounts payable
$627,185
Buy us a coffee
Neuphoria Therapeutics Inc. (NEUP)
Neuphoria Therapeutics Inc. (NEUP)